ACUD-1 is under clinical development by Accuitis and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success rate (PTSR) indication ...

Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success ...

Researchers say a compound called SYM2081 inhibits inflammation-driving mast cells in mice and human skin samples paving the ...

21,22,25-27,34,35 In cases of more extensive psoriasis, topical agents may be used in combination with phototherapy, or traditional systemic or biologic medications. 21-23,25-27,34,35 Rosacea is a ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

I'm a big K-beauty fan so, naturally, I love a hydrating essence. Because Palacios loves this brand, I decided to try the one ...

INR:0923. rummy circle app for ios FDA approves first topical minocycline treatment for rosacea The two ministries issued a list of prohibited and restri ...

INR:0494. is today match Novartis Piqray for PIK3CA mutation HR+/HER2- breast cancer: significantly prolonged survival The National Medical Insurance Bureau has re ...

INR:3407. mpl game online play FDA approves first topical minocycline treatment for rosacea Grifols acquires proteomics startup for $146 million Interpretati ...

Vee Mistry, CEO of SKINBYVEE shares what it takes to form strategic partnerships, put customers first, and pro-aging.

As the science of skin care continues to expand, some of those advances have landed directly in consumers’ hands. Is that a ...

lotterytickets 7Bit Casino free chip Novartis enters two collaborations for COVID-19 and pancreatic cancer treatments worth up to $767 million FDA approves first topical minocycline treatment for ...